Met Life Investment Management, LLC Concert Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$4.86 - $13.07 $65,021 - $174,863	-13,379 Closed	0 $0
Q4 2020 Jun 22, 2023	BUY	$9.48 - $12.84 $126,832 - $171,786	13,379 New	13,379 $169,000
Q3 2020 Jun 26, 2023	BUY	$8.67 - $10.82 $115,995 - $144,760	13,379 New	13,379 $131,000
Q2 2020 May 24, 2024	BUY	$7.8 - $11.52 $104,356 - $154,126	13,379 New	13,379 $133 Million
Q2 2020 Jun 26, 2023	BUY	$7.8 - $11.52 $104,356 - $154,126	13,379 New	13,379 $133,000
Q1 2020 Jul 12, 2023	BUY	$5.98 - $13.09 $80,006 - $175,131	13,379 New	13,379 $118,000
Q1 2020 Mar 22, 2023	BUY	$5.98 - $13.09 $26,347 - $57,674	4,406 Added 49.1%	13,379 $118,000
Q1 2020 May 15, 2020	BUY	$5.98 - $13.09 $80,006 - $175,131	13,379 New	13,379 $118,000
Q4 2019 Feb 14, 2020	SELL	$5.71 - $9.22 $51,235 - $82,731	-8,973 Closed	0 $0
Q3 2019 Jul 12, 2023	BUY	$5.88 - $12.35 $52,761 - $110,816	8,973 New	8,973 $52,000
Q2 2019 Jul 12, 2023	BUY	$9.44 - $13.12 $84,705 - $117,725	8,973 New	8,973 $107,000
Q1 2019 Jul 13, 2023	BUY	$12.07 - $17.54 $108,304 - $157,386	8,973 New	8,973 $108,000
Q4 2018 Jul 13, 2023	BUY	$11.25 - $16.17 $100,946 - $145,093	8,973 New	8,973 $112,000
Q4 2018 Mar 22, 2023	SELL	$11.25 - $16.17 $56,025 - $80,526	-4,980 Reduced 35.69%	8,973 $112,000
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $56,025 - $80,526	-4,980 Reduced 35.69%	8,973 $113,000
Q3 2018 Jul 13, 2023	BUY	$12.82 - $17.88 $115,033 - $160,437	8,973 New	8,973 $133,000
Q3 2018 Mar 22, 2023	BUY	$12.82 - $17.88 $178,877 - $249,479	13,953 New	13,953 $207,000
Q3 2018 Nov 14, 2018	BUY	$12.82 - $17.88 $63,843 - $89,042	4,980 Added 55.5%	13,953 $207,000
Q4 2017 Feb 15, 2018	BUY	$13.96 - $29.05 $125,263 - $260,665	8,973	8,973 $232,000

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account